Maytansine

CD19 molecule ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25856201 Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation. 2015 Jun 1 2
2 24023523 Targeting CD19 in B-cell lymphoma: emerging role of SAR3419. 2013 2
3 22003072 SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies. 2011 Oct 15 1